The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients.
- DOI
- 10.1128/spectrum.00211-22
- Published
- 2022 Apr 27
- Container
- Microbiology spectrum
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/spectrum.00211-22,
title = {The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients.},
author = {Tolan NV and Sherman AC and Zhou G and Nabel KG and Desjardins M and Melanson S and Kanjilal S and Moheed S and Kupelian J and Kaufman RM and Ryan ET and LaRocque RC and Branda JA and Dighe AS and Abraham J and Baden LR and Charles RC and Turbett SE},
year = {2022},
journal = {Microbiology spectrum},
doi = {10.1128/spectrum.00211-22},
url = {https://doi.org/10.1128/spectrum.00211-22}
}RIS
TY - JOUR TI - The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. AU - Tolan NV AU - Sherman AC AU - Zhou G AU - Nabel KG AU - Desjardins M AU - Melanson S AU - Kanjilal S AU - Moheed S AU - Kupelian J AU - Kaufman RM AU - Ryan ET AU - LaRocque RC AU - Branda JA AU - Dighe AS AU - Abraham J AU - Baden LR AU - Charles RC AU - Turbett SE PY - 2022 JO - Microbiology spectrum DO - 10.1128/spectrum.00211-22 UR - https://doi.org/10.1128/spectrum.00211-22 ER -
APA
NV, T., AC, S., G, Z., KG, N., M, D., S, M., S, K., S, M., J, K., RM, K., ET, R., RC, L., JA, B., AS, D., J, A., LR, B., RC, C., & SE, T. (2022). The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients.. Microbiology spectrum. https://doi.org/10.1128/spectrum.00211-22
Source records
- pubmed · retrieved 2026-09-26T20:34:03.130Z